SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls-Reference-Cited by-同舟云学术

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Published:2020-07-15 Issue:7821 Volume:584 Page:457-462
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Le Bert Nina,Tan Anthony T.,Kunasegaran Kamini,Tham Christine Y. L.,Hafezi Morteza,Chia Adeline,Chng Melissa Hui Yen,Lin Meiyin,Tan Nicole,Linster Martin,Chia Wan Ni,Chen Mark I-Cheng,Wang Lin-Fa^ORCID,Ooi Eng Eong^ORCID,Kalimuddin Shirin,Tambyah Paul Anantharajah,Low Jenny Guek-Hong^ORCID,Tan Yee-Joo,Bertoletti Antonio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-2550-z.pdf

Reference29 articles.

1. Welsh, R. M. & Selin, L. K. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2, 417–426 (2002).

2. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).

3. Raoult, D., Zumla, A., Locatelli, F., Ippolito, G. & Kroemer, G. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress 4, 66–75 (2020).

4. Lim, M. Q. et al. Cross-Reactivity and anti-viral function of dengue capsid and NS3-specific memory T cells toward Zika virus. Front. Immunol. 9, 2225 (2018).

5. Su, L. F., Kidd, B. A., Han, A., Kotzin, J. J. & Davis, M. M. Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults. Immunity 38, 373–383 (2013).

Cited by 1691 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the SARS-CoV-2 nucleocapsid protein;International Journal of Biological Macromolecules;2024-03

2. Ferritin-binding and ubiquitination-modified mRNA vaccines induce potent immune responses and protective efficacy against SARS-CoV-2;International Immunopharmacology;2024-03

3. Immunology of COVID-19 and Ineffective Immunity;Accelerating Diagnostics in a Time of Crisis;2024-02-29

4. Evaluation of the immunoprotective effects of porcine deltacoronavirus subunit vaccines;Virology;2024-02

5. Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults;International Journal of Infectious Diseases;2024-02